FDA Letter API

ReConserve of Maryland, Inc.

Letter data

Company
ReConserve of Maryland, Inc.
Recipient
Keith Rudd | Vice President, Environmental Health & Safety | ReConserve of Maryland, Inc. | 3220 Sun Street | Baltimore | , | MD | 21226-1050 | United States | krudd@reconserve.com
Issue date
2025-04-11
Posted date
Not available
FDA office
Division of Human and Animal Food Operations East II
Subject
Not available
Product
Food & Beverages
CMS ID
663413
Reference number
Not available
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER ReConserve of Maryland, Inc. MARCS-CMS 663413 — April 11, 2025 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: VIA EMAIL WITH READ RECEIPT: NO HARD COPY TO FOLLOW Product: Food & Beverages Recipient: Recipient Name Keith Rudd Recipient Title Vice President, Environmental Health & Safety ReConserve of Maryland, Inc. 3220 Sun Street Baltimore , MD 21226-1050 United States krudd@reconserve.com Issuing Office: Division of Human and Animal Food Operations East II United States April 11, 2025 Dear Keith Rudd, The United States Food and Drug Administration has completed evaluation of your facility’s corrective actions in response to our Warning Letter CMS 663413, dated January 3, 2024. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your facility from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your facility to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Justin N. Henson Branch Chief, Office of Surveillance and Compliance Center for Veterinary Medicine U.S. Food and Drug Administration U.S. Department of Health and Human Services Content current as of: 04/14/2025 Regulated Product(s) Food & Beverages